Breaking News Instant updates and real-time market news.

GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

07:39
02/07/18
02/07
07:39
02/07/18
07:39

GlaxoSmithKline reports Q4 adjusted EPS 27.2p vs. 25.5p a year ago

Reports Q4 revenue GBP 7.64B vs. GBP 7.59B a year ago. Emma Walmsley, Chief Executive Officer, GSK said: "In 2017 GSK delivered encouraging results from across the company with sales growth in each of our three global businesses, an improved Group operating margin, Adjusted EPS growth of 4% and stronger free cash flow. We are focused on competing effectively across our current portfolio and delivering three new launches which bring significant benefits to patients: Trelegy Ellipta which provides three medicines in a single inhaler to treat COPD; Juluca, the first 2-drug regimen, once-daily, single pill for HIV, helping to reduce the amount of medicines needed, and Shingrix, our new vaccine which represents a new standard for the prevention of shingles. Improving our Pharmaceuticals business remains our main priority and we are strengthening our pipeline with a focus on priority assets in two current therapy areas, Respiratory and HIV, and two potential areas, Oncology and Immuno-inflammation. We will provide a further update to investors at Q2 on our plans for R&D."

  • 07

    Feb

  • 25

    Mar

  • 23

    Apr

GSK GlaxoSmithKline
$35.99

0.5 (1.41%)

01/16/18
LEHM
01/16/18
UPGRADE
LEHM
Overweight
GlaxoSmithKline upgraded to Overweight from Equal Weight at Barclays
01/16/18
LEHM
01/16/18
UPGRADE
LEHM
Overweight
GlaxoSmithKline upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Emmanuel Papadakis upgraded GlaxoSmithKline to Overweight from Equal Weight and raised his price target for the shares to GBP 16.50 from GBP 14.50. The analyst believes concerns are now reflected in the valuation and consensus expectations while HIV and shingles offer "sustainable drivers of mid-term growth."
01/22/18
WBLR
01/22/18
NO CHANGE
WBLR
Outperform
Dynavax has sold off 30% since Heplisav approval, says William Blair
Dynavax (DVAX) shares have pulled back about 30% since the U.S. approval of Heplisav, the first and only two-dose hepatitis B vaccine that has demonstrated "superiority in efficacy and comparability" in safety to the standard of care, GlaxoSmithKline's (GSK) Engerix-B, William Blair analyst Katherine Xu tells investors in a research note. The analyst attributes the selloff to Dynavax electing to launch Heplisav on its own and the Street having insufficient confidence in the launch. She believes Heplisav has peak U.S. sales prospects of $600M and "provides a valuation floor." Xu also sees catalysts on the oncology side of the business. She maintains an Outperform rating on Dynavax with a $40 per share fair value estimate.
01/22/18
WELS
01/22/18
NO CHANGE
WELS
Underperform
Teva can't afford more pipeline setbacks, says Wells Fargo
After Teva (TEVA) reported that its Phase 3 registration study evaluating subcutaneously administered reslizumab in a pre-filled syringe did not meet its primary endpoint, Wells Fargo analyst David Maris said he believes this puts Teva at a disadvantage versus peers AstraZeneca (AZN) and GlaxoSmithKline (GSK) at a time when Teva cannot afford more pipeline setbacks. Subcutaneous reslizumab was not a major focus, but the news is still "another disappointment," said Maris, who keeps an Underperform rating on Teva shares.

TODAY'S FREE FLY STORIES

ABMD

Abiomed

$438.06

-8.23 (-1.84%)

05:00
06/22/18
06/22
05:00
06/22/18
05:00
Recommendations
Abiomed analyst commentary  »

Abiomed price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECL

Ecolab

$141.52

-2.14 (-1.49%)

04:57
06/22/18
06/22
04:57
06/22/18
04:57
Downgrade
Ecolab rating change  »

Ecolab downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

June PMI Composite Flash…

QGEN

Qiagen

$36.20

-0.23 (-0.63%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Qiagen participates in a conference call with William Blair »

CFO Sachers participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

June PMI Composite Flash…

AOBC

American Outdoor Brands

$12.80

-0.42 (-3.18%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
American Outdoor Brands management to meet with Wedbush »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NGVT

Ingevity

$82.89

-0.12 (-0.14%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Ingevity management to meet with Loop Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SBUX

Starbucks

$50.62

-1.6 (-3.06%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Starbucks management to meet with Wedbush »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 10

    Jul

AMGN

Amgen

$186.00

-0.51 (-0.27%)

, ARRY

Array BioPharma

$19.56

-0.43 (-2.15%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
European Society for Medical Oncology (ESMO) to hold a conference »

ESMO World Congress on…

AMGN

Amgen

$186.00

-0.51 (-0.27%)

ARRY

Array BioPharma

$19.56

-0.43 (-2.15%)

BAYRY

Bayer

$0.00

(0.00%)

HALO

Halozyme

$18.59

-0.88 (-4.52%)

INCY

Incyte

$72.47

-0.97 (-1.32%)

LLY

Eli Lilly

$86.07

-0.17 (-0.20%)

MRK

Merck

$61.17

-0.125 (-0.20%)

SHPG

Shire

$162.43

1.81 (1.13%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$39.02

-0.38 (-0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 23

    Jun

  • 28

    Jun

  • 30

    Jun

  • 30

    Jun

  • 10

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 21

    Dec

  • 28

    Jan

  • 22

    Mar

TAC

TransAlta

$4.95

(0.00%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
TransAlta management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

NUVA

NuVasive

$55.48

-1.18 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
NuVasive has a conference call hosted by JPMorgan »

JPMorgan Analyst Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

HUBG

Hub Group

$53.05

-0.8 (-1.49%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Hub Group management to meet with Loop Capital »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

PVAC

Penn Virginia

$79.38

-1.7 (-2.10%)

, ALOG

Analogic

$83.98

0.025 (0.03%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Hot Stocks
Penn Virginia to replace Analogic in S&P 600 at open on June 22 »

Altaris Capital Partners…

PVAC

Penn Virginia

$79.38

-1.7 (-2.10%)

ALOG

Analogic

$83.98

0.025 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLR

Fluor

$48.68

-1.035 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Fluor management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Macquarie to hold a summit »

Emerging Industries…

INST

Instructure

$45.00

-1.675 (-3.59%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Instructure management to meet with Needham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 26

    Jun

RLH

Red Lion Hotels

$11.70

-0.15 (-1.27%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Red Lion Hotels management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Stephens food/agribusiness analyst to hold an analyst/industry conference call »

Food & Agribusiness…

04:55
06/22/18
06/22
04:55
06/22/18
04:55
General news
Breaking General news story  »

Week of 6/22 Baker-Hughes…

NUVA

NuVasive

$55.48

-1.18 (-2.08%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
NuVasive management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 22

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

IRTC

iRhythm

$79.00

-1.67 (-2.07%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
iRhythm management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EURN

Euronav NV

$9.80

0.1 (1.03%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Euronav NV management to meet with Seaport Global »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

PRMW

Primo Water

$17.78

0.02 (0.11%)

04:55
06/22/18
06/22
04:55
06/22/18
04:55
Conference/Events
Primo Water management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

SWN

Southwestern Energy

$5.27

-0.105 (-1.95%)

04:54
06/22/18
06/22
04:54
06/22/18
04:54
Recommendations
Southwestern Energy analyst commentary  »

Southwestern Energy price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

AMSWA

American Software

$14.94

-0.21 (-1.39%)

04:52
06/22/18
06/22
04:52
06/22/18
04:52
Recommendations
American Software analyst commentary  »

American Software price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.